Literature DB >> 22658643

Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseases.

Joon Seol Bae1, Jeong-Hyun Kim, Charisse Flerida A Pasaje, Hyun Sub Cheong, Tae Hoon Lee, In Song Koh, Hyo-Suk Lee, Yoon Jun Kim, Hyoung Doo Shin.   

Abstract

BACKGROUND AND AIMS: MicroRNAs have been recently identified as important regulators that influence human carcinogenesis, cancer progression, and the interaction between the host and virus. This study investigates an association between microRNAs (miR-101-1, miR-101-2, and miR-338) and the risk of liver diseases through clearance of hepatitis B virus infection, development of liver cirrhosis, and hepatocellular carcinoma occurrence.
METHODS: Genetic variations were genotyped using the TaqMan assay in 1439 Korean hepatitis B virus patients. To investigate the relationship between four polymorphisms in three microRNAs and the disease phenotypes, differences in frequency distribution of variations were analysed using logistic and multiple regression analyses after adjusting for age and gender as covariates.
RESULTS: We find that the rs7536540 polymorphism in miR-101-1 is significantly associated with development of liver cirrhosis and hepatocellular carcinoma occurrence. In addition, rs12375841 and its unique haplotype (ht2) in miR-101-2 show significant association with clearance of hepatitis B virus infection.
CONCLUSIONS: To our knowledge, this is the first study to examine a relationship between the three microRNA genes and the risk of hepatitis B-related liver diseases. We expect that the findings in this study will be helpful to further genetic studies in the pathophysiology of hepatitis B virus-related liver diseases.
Copyright © 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22658643     DOI: 10.1016/j.dld.2012.04.021

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  20 in total

Review 1.  Epigenetics of hepatocellular carcinoma: role of microRNA.

Authors:  Sharad Khare; Qiong Zhang; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 2.  Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Authors:  Joseph George; Tushar Patel
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

3.  MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis.

Authors:  Fujun Yu; Zhongqiu Lu; Jing Cai; Kate Huang; Bicheng Chen; Guojun Li; Peihong Dong; Jianjian Zheng
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  miRNA as activity markers in Parvo B19 associated heart disease.

Authors:  U Kühl; M Rohde; D Lassner; U M Gross; F Escher; H-P Schultheiss
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

5.  MicroRNA-101 polymorphisms and risk of head and neck squamous cell carcinoma in a Chinese population.

Authors:  Limin Miao; Lihua Wang; Hua Yuan; Dong Hang; Longbiao Zhu; Jiangbo Du; Xun Zhu; Bing Li; Ruixia Wang; Hongxia Ma; Ning Chen
Journal:  Tumour Biol       Date:  2015-10-22

6.  Gastric juice miR-129 as a potential biomarker for screening gastric cancer.

Authors:  Xing Yu; Lin Luo; Yibo Wu; Xiuchong Yu; Yang Liu; Xuelin Yu; Xiaoyan Zhao; Xinjun Zhang; Long Cui; Guoliang Ye; Yanping Le; Junming Guo
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

Review 7.  Complex interactions between microRNAs and hepatitis B/C viruses.

Authors:  Hong-Xia Fan; Hua Tang
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 8.  MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.

Authors:  Jie Sun; Haiqi Lu; Xian Wang; Hongchuan Jin
Journal:  ScientificWorldJournal       Date:  2013-02-04

Review 9.  Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.

Authors:  B Alipoor; S Nikouei; F Rezaeinejad; S-N Malakooti-Dehkordi; Z Sabati; H Ghasemi
Journal:  J Endocrinol Invest       Date:  2021-04-01       Impact factor: 4.256

Review 10.  Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk.

Authors:  Kshitij Srivastava; Anvesha Srivastava
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.